Active, Not Recruiting
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL
NCT03836261
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Research Site Los Angeles, California, United States
- Research Site Redondo Beach, California, United States
- Research Site Fort Wayne, Indiana, United States
- Research Site Wichita, Kansas, United States